Parkinson's Medications: What Works, What Doesn't, What's Dangerous

When my mom was first diagnosed with Parkinson's, her neurologist started listing medications, side effects, and treatment options. I nodded like I understood everything. Then we walked out to the parking lot and I thought: "I have absolutely no idea what he just said." If you've ever looked at a Parkinson's medication list and felt completely overwhelmed, this video is for you. I'm breaking down every major Parkinson's medication in plain English—what it does, how it works, and what to watch for. ⚠️ DISCLAIMER: I'm not a doctor. This is educational content based on my experience caring for my mom and research into published medical information. Always consult your neurologist about medication decisions. 💊 MEDICATIONS COVERED: *Carbidopa-Levodopa* (Sinemet, Rytary, Duopa *MAO-B Inhibitors* (Rasagiline, Selegiline, Safinamide) *Dopamine Agonists* (Pramipexole, Ropinirole, Rotigotine patch) *COMT Inhibitors* (Entacapone, Opicapone, Tolcapone) *Amantadine* (Gocovri, Osmolex ER) *Anticholinergics* (Trihexyphenidyl/Artane, Benztropine) 🎯 KEY TAKEAWAYS: ⚠️ CRITICAL SAFETY NOTES: Dopamine agonists can cause impulse control issues that develop slowly Anticholinergics can cause confusion/memory problems in older adults If something feels "off," trust your gut and call the doctor Never stop Parkinson's medications abruptly without medical guidance 🧠 WHAT THIS VIDEO COVERS: This video focuses on medications for MOTOR symptoms (movement). Non-motor symptoms like sleep problems, anxiety, constipation, and hallucinations will be covered next week. 📌 TIMESTAMPS: 0:00 - "I Have No Idea What He Just Said" 1:04 - Introduction 1:33 - Carbidopa-Levodopa (The Gold Standard 2:57 - MAO-B Inhibitors (Helping Dopamine Last) 3:56 - Dopamine Agonists (IMPULSE CONTROL WARNING) 5:24 - COMT Inhibitors (Making Levodopa Last Longer) 6:22 - Amantadine (The Antiviral That Helps Parkinson's) 7:28 - Anticholinergics (Older Tremor Medications) 8:51 - The Big Picture: It's a System, Not One Pill 9:22 - Closing Thoughts 💡 WHY UNDERSTANDING MEDICATIONS MATTERS: Gives you confidence to ask questions Helps you recognize side effects early Lets you advocate for yourself or your loved one Reduces that overwhelmed feeling Helps you feel more in control ❓ QUESTIONS FOR YOU: Which medication surprised you most? Have you experienced any of these side effects? What medication questions do you still have? Drop your thoughts in the comments—I read every one! 🔔 SUBSCRIBE for weekly Parkinson's videos 📺 RELATED VIDEOS: What Moved to Phase 3 in 2025-2026:    • 5 Promising Parkinson's Treatments Moving ...   Promising Phase 2 Trials to Watch:    • Promising Phase 2 Parkinson's Trials to Wa...   Top 5 Parkinson's Treatments to Watch in 2026    • Top 5 Parkinson's Treatments to Watch in 2...   Parkinson's Vaccine Update    • The Parkinson's Vaccine Just Released Phas...   --- DISCLAIMER: I'm not a doctor. My mom lived with Parkinson's for over a decade, and I create these videos to help families navigate the overwhelming amount of information. This is educational content, not medical advice. Always consult your neurologist before starting, stopping, or changing any medications. #ParkinsonsDisease #ParkinsonsMedications #Sinemet #CarbidopaLevodopa #DopamineAgonists #MAOBInhibitors #ParkinsonsEducation #CarbiLevodopa #ParkinsonsCare #parkinsonsawareness ☕ Support my work: https://buymeacoffee.com/heykimmi sources: General Resources: Parkinson's Foundation: parkinson.org/medication American Parkinson Disease Association (APDA) National Institute of Neurological Disorders and Stroke (NINDS) Key Publications: LeWitt PA, Fahn S. "Levodopa therapy for Parkinson disease" - Neurology 86(14 Suppl 1):S3-12 (2016) - PMID: 27044852 Weintraub D, et al. "Impulse control disorders in Parkinson disease" - Arch Neurol 67(5):589-595 (2010) - PMID: 20457959 Olanow CW, et al. "Rasagiline in Parkinson's disease" - NEJM 361(13):1268-1278 (2009) - PMID: 19776408 Elmer LW, et al. "Amantadine for dyskinesia in Parkinson's disease" - CNS Drugs 32(4):387-398 (2018) - PMID: 29623596 Fox SH, et al. "Evidence-Based Medicine Review: Motor Symptoms of Parkinson's Disease" - Mov Disord 33(8):1248-1266 (2018) - PMID: 29570866 FDA Resources: FDA Warning on Impulse Control Disorders with Dopamine Agonists